- Home
- DRUG vs TRAK Comparison
DRUG vs TRAK Comparison
Compare DRUG & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- TRAK
- Stock Information
- Founded
- DRUG 2019
- TRAK 1990
- Country
- DRUG United States
- TRAK United States
- Employees
- DRUG N/A
- TRAK N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- TRAK EDP Services
- Sector
- DRUG Health Care
- TRAK Technology
- Exchange
- DRUG Nasdaq
- TRAK Nasdaq
- Market Cap
- DRUG 345.6M
- TRAK 374.5M
- IPO Year
- DRUG N/A
- TRAK 1998
- Fundamental
- Price
- DRUG $45.43
- TRAK $16.97
- Analyst Decision
- DRUG Strong Buy
- TRAK
- Analyst Count
- DRUG 9
- TRAK 0
- Target Price
- DRUG $81.67
- TRAK N/A
- AVG Volume (30 Days)
- DRUG 70.6K
- TRAK 49.1K
- Earning Date
- DRUG 08-11-2025
- TRAK 11-13-2025
- Dividend Yield
- DRUG N/A
- TRAK 0.47%
- EPS Growth
- DRUG N/A
- TRAK 21.41
- EPS
- DRUG N/A
- TRAK 0.34
- Revenue
- DRUG N/A
- TRAK $22,028,373.00
- Revenue This Year
- DRUG N/A
- TRAK $15.18
- Revenue Next Year
- DRUG N/A
- TRAK $10.00
- P/E Ratio
- DRUG N/A
- TRAK $50.25
- Revenue Growth
- DRUG N/A
- TRAK 9.73
- 52 Week Low
- DRUG $0.94
- TRAK $15.12
- 52 Week High
- DRUG $79.02
- TRAK $25.01
- Technical
- Relative Strength Index (RSI)
- DRUG 57.15
- TRAK 50.89
- Support Level
- DRUG $39.70
- TRAK $16.89
- Resistance Level
- DRUG $49.49
- TRAK $17.39
- Average True Range (ATR)
- DRUG 3.14
- TRAK 0.49
- MACD
- DRUG 0.13
- TRAK 0.13
- Stochastic Oscillator
- DRUG 64.66
- TRAK 78.25
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About TRAK ReposiTrak Inc.
ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.